BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21068094)

  • 41. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis.
    Szodoray P; Szabó Z; Kapitány A; Gyetvai A; Lakos G; Szántó S; Szücs G; Szekanecz Z
    Autoimmun Rev; 2010 Jan; 9(3):140-3. PubMed ID: 19427413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor.
    Vander Cruyssen B; Peene I; Cantaert T; Hoffman IE; De Rycke L; Veys EM; De Keyser F
    Autoimmun Rev; 2005 Sep; 4(7):468-74. PubMed ID: 16137613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
    Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis.
    Koivula MK; Aman S; Alasaarela E; Karjalainen A; Hakala M; Risteli J
    Rheumatology (Oxford); 2006 Nov; 45(11):1364-9. PubMed ID: 16632481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies.
    Gyetvai A; Szekanecz Z; Soós L; Szabó Z; Fekete A; Kapitány A; Teodorescu M; Sipka S; Szegedi G; Lakos G
    Rheumatology (Oxford); 2010 Jan; 49(1):25-33. PubMed ID: 19920092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis.
    Rodríguez-Mahou M; López-Longo FJ; Sánchez-Ramón S; Estecha A; García-Segovia A; Rodríguez-Molina JJ; Carreño L; Fernández-Cruz E
    Arthritis Rheum; 2006 Aug; 55(4):657-61. PubMed ID: 16874789
    [No Abstract]   [Full Text] [Related]  

  • 49. Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis.
    Montano-Loza A; Czaja AJ; Carpenter HA; Piette A; Murphy D; Shums Z; Burlingame R; Norman GL
    Autoimmunity; 2006 Jun; 39(4):341-8. PubMed ID: 16891223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis.
    Vander Cruyssen B; Nogueira L; Van Praet J; Deforce D; Elewaut D; Serre G; De Keyser F
    Ann Rheum Dis; 2008 Apr; 67(4):542-6. PubMed ID: 17644546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating plasmablasts/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritis.
    Kerkman PF; Rombouts Y; van der Voort EI; Trouw LA; Huizinga TW; Toes RE; Scherer HU
    Ann Rheum Dis; 2013 Jul; 72(7):1259-63. PubMed ID: 23625975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis.
    Stolt P; Yahya A; Bengtsson C; Källberg H; Rönnelid J; Lundberg I; Klareskog L; Alfredsson L;
    Ann Rheum Dis; 2010 Jun; 69(6):1072-6. PubMed ID: 19966090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays.
    Vander Cruyssen B; Cantaert T; Nogueira L; Clavel C; De Rycke L; Dendoven A; Sebag M; Deforce D; Vincent C; Elewaut D; Serre G; De Keyser F
    Arthritis Res Ther; 2006; 8(4):R122. PubMed ID: 16859515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
    Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
    Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels.
    Bos WH; Ursum J; de Vries N; Bartelds GM; Wolbink GJ; Nurmohamed MT; van der Horst-Bruinsma IE; van de Stadt RJ; Crusius JB; Tak PP; Dijkmans BA; van Schaardenburg D
    Ann Rheum Dis; 2008 Sep; 67(9):1347-50. PubMed ID: 18388157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence.
    Lundström SL; Fernandes-Cerqueira C; Ytterberg AJ; Ossipova E; Hensvold AH; Jakobsson PJ; Malmström V; Catrina AI; Klareskog L; Lundberg K; Zubarev RA
    PLoS One; 2014; 9(11):e113924. PubMed ID: 25426976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibodies to citrullinated proteins in arthritis: pathology and promise.
    Klareskog L; Widhe M; Hermansson M; Rönnelid J
    Curr Opin Rheumatol; 2008 May; 20(3):300-5. PubMed ID: 18388522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoantibodies to citrullinated proteins: ACPA.
    Vincent C; Nogueira L; Clavel C; Sebbag M; Serre G
    Autoimmunity; 2005 Feb; 38(1):17-24. PubMed ID: 15804701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal anti-citrullinated protein antibodies selected on citrullinated fibrinogen have distinct targets with different cross-reactivity patterns.
    van de Stadt LA; van Schouwenburg PA; Bryde S; Kruithof S; van Schaardenburg D; Hamann D; Wolbink G; Rispens T
    Rheumatology (Oxford); 2013 Apr; 52(4):631-5. PubMed ID: 23264551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue.
    Vossenaar ER; Smeets TJ; Kraan MC; Raats JM; van Venrooij WJ; Tak PP
    Arthritis Rheum; 2004 Nov; 50(11):3485-94. PubMed ID: 15529392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.